Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Atlas Arteria (ASX: ALX) has once again urged shareholders to reject a revised takeover proposal from IFM Global Infrastructure Fund, arguing that the latest offer still fails to reflect the true value of the Australian toll road operator.
On Monday, IFM Global increased its acquisition bid to A$5.10 per share from its previous offer of A$4.75 per share, valuing Atlas Arteria at approximately A$7.4 billion (US$5.23 billion). Despite the higher proposal, Atlas maintained that the offer significantly undervalues the company’s long-term growth prospects, infrastructure assets, and future earnings potential.
IFM described the revised bid as its “best and final” offer, signaling that it does not intend to further increase the purchase price. However, Atlas’ board remains unconvinced, reiterating its recommendation that shareholders take no action regarding the proposal.
The latest development follows Atlas Arteria’s rejection of IFM’s earlier bid. The company has consistently argued that its portfolio of toll road assets and strategic infrastructure investments justify a higher valuation. Atlas also cautioned IFM against pursuing a hostile takeover strategy after reports emerged that the infrastructure investor was considering an “on-market raid” to increase its ownership stake in the company.
Market reaction to the announcement was relatively muted. Atlas Arteria shares gained 0.6% during Monday’s trading session, underperforming the broader Australian market. In comparison, the benchmark S&P/ASX 200 index advanced 1.3%.
The ongoing takeover battle has attracted significant attention from investors across Australia’s infrastructure sector. Analysts believe the dispute highlights differing views on the value of major transport infrastructure assets amid growing demand for stable, long-term investment opportunities.
As the situation develops, shareholders will closely monitor whether IFM maintains its current position or explores alternative strategies to secure a larger stake in Atlas Arteria. For now, the company remains firm in its stance that the A$7.4 billion takeover offer does not adequately compensate investors for the value of its business.
